Krebs Andreas (CIK 1438946) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-15). Recent activity: Buy DFTX (4,666 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-15 | Definium Therapeutics, Inc. (DFTX) | Director | Buy | 4,666 | $0 |
Source: SEC Form 4 filings · as of 2026-06-15